Demographic and clinical characteristics of patients with major depressive disorder and controls
| Group; mean (SD)*† | |||
|---|---|---|---|
| Characteristic | Reboxetine, n = 8 | Citalopram, n = 12 | Controls, n = 20 |
| Age, yr, mean | 36.1 (10.8) | 42.4 (12.8) | 37.6 (10.8) |
| School education, yr | 10.5 (1.4) | 10.5 (1.2) | 10.8 (1.2) |
| Sex, female:male | 7:1 | 11:1 | 18:2 |
| Age at onset, yr | 34.3 (12.0) | 30.9 (12.2) | – |
| Duration of illness, yr | 8.3 (6.4) | 5.2 (7.7) | – |
| No. of previous episodes | 1.3 (0.8) | 1.0 (1.3) | – |
| Logical IQ score | 98.6 (10.4) | 104.8 (13.5) | |
| Trail Making Test20 Part A score | 34.8 (9.1) | 35.7 (16.5) | – |
| Trail Making Test20 Part B score | 80.6 (25.8) | 77.2 (31.6) | – |
| Before treatment | |||
| HRSD score | 24.4 (4.7) | 23.4 (4.4) | – |
| BDI score | 25.5 (8.1) | 25.5 (11.3) | 3.6 (8.3) |
| After treatment | |||
| HRSD score | 8.8 (5.8) | 8.3 (6.3) | – |
| BDI score | 16.3 (11.2) | 15.1 (12.1) | – |
| Treatment response, % change in HRSD score | 65.5 (16.5) | 66.2 (23.7) | – |
| No. of patients in remission after treatment (HRSD score < 7) | 4 | 6 | – |